Business, energy, technology, markets and global industry news from Business News Today

Nipro Corporation

Medical Devices & Diagnostics

Nipro says ELISIO-HX can improve dialysis without new machines. Will better toxin removal translate into better outcomes?

Nipro Corporation has commercially launched its FDA-cleared ELISIO-HX dialyzer in the United States, offering dialysis providers a medium cut-off membrane designed to remove larger uremic toxins through existing hemodialysis equipment and workflows.

Read More
Pharma & Biotech

Samsung Bioepis targets Japan’s autoimmune market with ustekinumab biosimilar debut

Japan needs lower biologic costs. Samsung Bioepis’s NIPRO launch tests whether ustekinumab biosimilars can shift autoimmune care.

Read More
Pharma & Biotech

Ustekinumab biosimilar approved in Japan: Can Samsung Bioepis expand its global autoimmune footprint?

Samsung Bioepis secures Japan approval for its ustekinumab biosimilar with Nipro, marking a key step in Asia's biosimilar adoption. Find out what this means.

Read More